Research Article
Time Series Modeling of Tuberculosis Cases in India from 2017 to 2022 Based on the SARIMA-NNAR Hybrid Model
Table 1
Monthly reported notified TB cases from January 2017 to December 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
According to the WHO, the COVID-19 pandemic has had a significant impact on TB diagnosis and treatment in India. The ensuing disruptions from the health crisis arising out of the COVID pandemic have prompted lags in diagnosis and the beginning of treatment, which has resulted in a 25% annual shortfall in TB case notifications in 2020 compared with 2019 [41]. In addition, the COVID pandemic has led to the absolute mobilization of healthcare efforts and infrastructure towards its control and management, leaving no attention to other afflictions such as TB and others. |